PDL BioPharma Articles

PDL files for arbitration for alleged royalties underpayments by Genentech

11 June 2013

US Nevada state judge denies Roche and Genentech motions to dismiss PDL BioPharma's royalties complaint

12 July 2011

PDL BioPharma to pay MedImmune $92.5 million to resolve patent disputes; Mylan debuts generic Vfend

17 February 2011

Roche/Genentech’s Lucentis meets goals in diabetic macular edema patient study

14 February 2011

UCB and PDL settle patent disputes over Cimzia; Natco challenges Gilead’s Tamiflu

8 February 2011

PDL BioPharma sues Roche’s Genentech over royalties

2 September 2010

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end